Article Type
Changed
Mon, 07/23/2018 - 08:08
Display Headline
How should we advise patients about the contraceptive patch, given the FDA warning?
Article PDF
Author and Disclosure Information

Holly L. Thacker, MD
Director, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Tommaso Falcone, MD
Chairman, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Ashish Atreja, MD, MPH
Associate Program Director, Medical Informatics Fellowship, Department of General Internal Medicine, The Cleveland Clinic Foundation

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

C. Martin Harris, MD, MBA
Chief Information Officer, Chairman, Information Technology Division, Department of Internal Medicine, The Cleveland Clinic Foundation

Address: Holly L. Thacker, MD, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 73(1)
Publications
Topics
Page Number
45-47
Sections
Author and Disclosure Information

Holly L. Thacker, MD
Director, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Tommaso Falcone, MD
Chairman, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Ashish Atreja, MD, MPH
Associate Program Director, Medical Informatics Fellowship, Department of General Internal Medicine, The Cleveland Clinic Foundation

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

C. Martin Harris, MD, MBA
Chief Information Officer, Chairman, Information Technology Division, Department of Internal Medicine, The Cleveland Clinic Foundation

Address: Holly L. Thacker, MD, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

Author and Disclosure Information

Holly L. Thacker, MD
Director, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Tommaso Falcone, MD
Chairman, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case-Western Reserve University

Ashish Atreja, MD, MPH
Associate Program Director, Medical Informatics Fellowship, Department of General Internal Medicine, The Cleveland Clinic Foundation

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic Foundation

C. Martin Harris, MD, MBA
Chief Information Officer, Chairman, Information Technology Division, Department of Internal Medicine, The Cleveland Clinic Foundation

Address: Holly L. Thacker, MD, Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(1)
Issue
Cleveland Clinic Journal of Medicine - 73(1)
Page Number
45-47
Page Number
45-47
Publications
Publications
Topics
Article Type
Display Headline
How should we advise patients about the contraceptive patch, given the FDA warning?
Display Headline
How should we advise patients about the contraceptive patch, given the FDA warning?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media